Umur Hatipoglu
Overview
Explore the profile of Umur Hatipoglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
663
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nathani A, Nanah A, Al-Jaghbeer M, Meli Y, Wisen D, Marsili L, et al.
Respir Care
. 2025 Feb;
PMID: 39969933
COPD is a heterogeneous disorder. We developed a multidisciplinary evaluation scheme to identify patients with COPD who may benefit from phenotype-specific therapy. Our team of general and interventional pulmonologists, thoracic...
2.
Manek G, Zhang S, Krishtopaytis E, Perelas A, Khirfan G, Paul D, et al.
Chest
. 2025 Jan;
PMID: 39805515
No abstract available.
3.
Raghavan S, Hatipoglu U, Aboussouan L
Curr Opin Pulm Med
. 2024 Dec;
31(2):156-164.
PMID: 39620703
Purpose Of Review: The diagnosis of chronic obstructive pulmonary disease (COPD) encompasses heterogeneous pathophysiological mechanisms which can shape an individual patient's experience. This paper reviews available therapeutic options for the...
4.
Hatipoglu U, Dean J, Aboussouan L
Am J Respir Crit Care Med
. 2024 Oct;
211(3):518-519.
PMID: 39405550
No abstract available.
5.
Chatburn R, Hatipoglu U
Respir Care
. 2024 Oct;
69(11):1484-1486.
PMID: 39379163
No abstract available.
6.
Attaway A, Mehra R, Zein J, Hatipoglu U, Grund M, Orsini E, et al.
Ann Am Thorac Soc
. 2024 Jun;
21(9):1316-1325.
PMID: 38843487
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. Our previous studies have identified that nocturnal hypoxemia causes skeletal muscle loss (i.e., sarcopenia) in models of...
7.
LaFon D, Helgeson E, Lindberg S, Voelker H, Bhatt S, Casaburi R, et al.
JAMA Netw Open
. 2024 May;
7(5):e247535.
PMID: 38771577
Importance: While β-blockers are associated with decreased mortality in cardiovascular disease (CVD), exacerbation-prone patients with chronic obstructive pulmonary disease (COPD) who received metoprolol in the Beta-Blockers for the Prevention of...
8.
Attaway A, Lopez R, Welch N, Bellar A, Hatipoglu U, Zein J, et al.
BMC Pulm Med
. 2024 Apr;
24(1):186.
PMID: 38632546
Background: Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disorder with systemic consequences that can cause a muscle loss phenotype (MLP), which is characterized by the loss of muscle...
9.
Hatipoglu U, Lewarski J, Chatburn R
Respir Care
. 2024 Jan;
69(5):621-626.
PMID: 38290749
The purpose of this article is to identify (by brand name) and then classify the modes available on contemporary portable ventilators used for noninvasive ventilation in the United States. We...
10.
Hatipoglu U, Lewarski J, Chatburn R
Respir Care
. 2023 Sep;
68(10):1479-1480.
PMID: 37722732
No abstract available.